Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MMAC-SF | Vemurafenib | Dasatinib | 0.316 | 0.000 | uM | 72 | hr | 2 | 859 | 151 | 0.5423 | 0.5371 | 0.1758 | 0.1786 |
MMAC-SF | Vemurafenib | Dasatinib | 0.316 | 0.000 | uM | 72 | hr | 3 | 938 | 162 | 0.5943 | 0.5371 | 0.1727 | 0.1786 |
MMAC-SF | Vemurafenib | Dasatinib | 0.316 | 0.316 | uM | 72 | hr | 1 | 782 | 102 | 0.5208 | 0.5813 | 0.1304 | 0.1242 |
MMAC-SF | Vemurafenib | Dasatinib | 0.316 | 0.316 | uM | 72 | hr | 2 | 936 | 129 | 0.6181 | 0.5813 | 0.1378 | 0.1242 |
MMAC-SF | Vemurafenib | Dasatinib | 0.316 | 0.316 | uM | 72 | hr | 3 | 882 | 92 | 0.6051 | 0.5813 | 0.1043 | 0.1242 |
MMAC-SF | Vemurafenib | Dasatinib | 0.316 | 1.000 | uM | 72 | hr | 1 | 957 | 86 | 0.6671 | 0.5652 | 0.0899 | 0.0909 |
MMAC-SF | Vemurafenib | Dasatinib | 0.316 | 1.000 | uM | 72 | hr | 2 | 742 | 58 | 0.5239 | 0.5652 | 0.0782 | 0.0909 |
MMAC-SF | Vemurafenib | Dasatinib | 0.316 | 1.000 | uM | 72 | hr | 3 | 736 | 77 | 0.5047 | 0.5652 | 0.1046 | 0.0909 |
MMAC-SF | Vemurafenib | Dasatinib | 0.316 | 3.160 | uM | 72 | hr | 1 | 976 | 91 | 0.6778 | 0.5614 | 0.0932 | 0.0959 |
MMAC-SF | Vemurafenib | Dasatinib | 0.316 | 3.160 | uM | 72 | hr | 2 | 873 | 73 | 0.6127 | 0.5614 | 0.0836 | 0.0959 |
MMAC-SF | Vemurafenib | Dasatinib | 0.316 | 3.160 | uM | 72 | hr | 3 | 578 | 64 | 0.3937 | 0.5614 | 0.1107 | 0.0959 |
MMAC-SF | Vemurafenib | Dasatinib | 1.000 | 0.000 | uM | 72 | hr | 1 | 660 | 203 | 0.3500 | 0.3972 | 0.3076 | 0.3126 |
MMAC-SF | Vemurafenib | Dasatinib | 1.000 | 0.000 | uM | 72 | hr | 2 | 743 | 233 | 0.3906 | 0.3972 | 0.3136 | 0.3126 |
MMAC-SF | Vemurafenib | Dasatinib | 1.000 | 0.000 | uM | 72 | hr | 3 | 862 | 273 | 0.4511 | 0.3972 | 0.3167 | 0.3126 |
MMAC-SF | Vemurafenib | Dasatinib | 1.000 | 0.316 | uM | 72 | hr | 1 | 616 | 148 | 0.3584 | 0.4029 | 0.2403 | 0.2375 |
MMAC-SF | Vemurafenib | Dasatinib | 1.000 | 0.316 | uM | 72 | hr | 2 | 707 | 170 | 0.4113 | 0.4029 | 0.2405 | 0.2375 |
MMAC-SF | Vemurafenib | Dasatinib | 1.000 | 0.316 | uM | 72 | hr | 3 | 746 | 173 | 0.4389 | 0.4029 | 0.2319 | 0.2375 |
MMAC-SF | Vemurafenib | Dasatinib | 1.000 | 1.000 | uM | 72 | hr | 1 | 932 | 231 | 0.5369 | 0.4583 | 0.2479 | 0.2119 |
MMAC-SF | Vemurafenib | Dasatinib | 1.000 | 1.000 | uM | 72 | hr | 2 | 769 | 142 | 0.4802 | 0.4583 | 0.1847 | 0.2119 |
MMAC-SF | Vemurafenib | Dasatinib | 1.000 | 1.000 | uM | 72 | hr | 3 | 586 | 119 | 0.3577 | 0.4583 | 0.2031 | 0.2119 |
MMAC-SF | Vemurafenib | Dasatinib | 1.000 | 3.160 | uM | 72 | hr | 1 | 898 | 135 | 0.5844 | 0.4386 | 0.1503 | 0.1472 |
MMAC-SF | Vemurafenib | Dasatinib | 1.000 | 3.160 | uM | 72 | hr | 2 | 652 | 111 | 0.4143 | 0.4386 | 0.1702 | 0.1472 |
MMAC-SF | Vemurafenib | Dasatinib | 1.000 | 3.160 | uM | 72 | hr | 3 | 471 | 57 | 0.3171 | 0.4386 | 0.1210 | 0.1472 |
MMAC-SF | Vemurafenib | Dasatinib | 3.160 | 0.000 | uM | 72 | hr | 1 | 600 | 222 | 0.2895 | 0.2946 | 0.3700 | 0.4049 |
MMAC-SF | Vemurafenib | Dasatinib | 3.160 | 0.000 | uM | 72 | hr | 2 | 679 | 274 | 0.3102 | 0.2946 | 0.4035 | 0.4049 |